Evogene Ltd. - Ordinary Shares (EVGN): Price and Financial Metrics

Evogene Ltd. - Ordinary Shares (EVGN)

Today's Latest Price: $3.37 USD

0.11 (-3.16%)

Updated Dec 2 4:00pm

Add EVGN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 27 in Agriculture

See all "A" rated Strong Buy stocks

EVGN Stock Summary

  • With a price/sales ratio of 119.02, Evogene Ltd has a higher such ratio than 97.21% of stocks in our set.
  • As for revenue growth, note that EVGN's revenue has grown -93.23% over the past 12 months; that beats the revenue growth of just 1.12% of US companies in our set.
  • The volatility of Evogene Ltd's share price is greater than that of 95.66% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to EVGN, based on their financial statements, market capitalization, and price volatility, are ORMP, PIRS, KALV, LOGC, and SYBX.
  • EVGN's SEC filings can be seen here. And to visit Evogene Ltd's official web site, go to www.evogene.com.

EVGN Stock Price Chart Interactive Chart >

Price chart for EVGN

EVGN Price/Volume Stats

Current price $3.37 52-week high $5.30
Prev. close $3.48 52-week low $0.75
Day low $3.11 Volume 975,175
Day high $3.68 Avg. volume 387,910
50-day MA $3.26 Dividend yield N/A
200-day MA $1.78 Market Cap 86.78M

Evogene Ltd. - Ordinary Shares (EVGN) Company Bio

Evogene Ltd. operates as a plant genomics company that uses a technology infrastructure to enhance seed traits underlying crop productivity. The company was founded in 1999 and is based in Rehovot, Israel.

EVGN Latest News Stream

Event/Time News Detail
Loading, please wait...

EVGN Latest Social Stream

Loading social stream, please wait...

View Full EVGN Social Stream

Latest EVGN News From Around the Web

Below are the latest news stories about Evogene Ltd that investors may wish to consider to help them evaluate EVGN as an investment opportunity.

Biomica Announces Positive Pre-Clinical Results in its Immuno-Oncology Program

REHOVOT, Israel, Sept. 8, 2020 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced positive pre-clinical in-vivo results in its…

PR Newswire | September 8, 2020

The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp ...

Benzinga | September 3, 2020

Evogene Secures $10M In ARK Investment-Lead Funding Round

Biotechnology company Evogene Ltd . (NASDAQ: EVGN ) (TASE: EVGN.TA) confirmed Tuesday it has secured $10 million in financing through an investment offering. Technology investment firm ARK Investment Management, LLC and Alpha Capital Anstalt agreed to invest $7 million and $3 million in the Rehovot, Israel-based company. The registered direct offering of ordinary shares valued at $1.7 per … Full story available on Benzinga.com

Benzinga | September 2, 2020

The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG ) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Catalent Inc (NYSE: CTLT ) Evogene Ltd (NASDAQ: EVGN ) (announced $10 million equity investment led by ARK Investment Management) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 1) Acasti Pharma Inc (NASDAQ: ACST ) ADiTx Therapeutics...

Benzinga | September 2, 2020

Evogene announces $10M investment

Evogene ([[EVGN]] +8.2%) enters into a definitive agreement with ARK Investment Management and Alpha Capital Anstalt in connection with a registered direct offering of ordinary shares at a price of $1.70 per share, for an aggregate cash consideration of $10M.ARK Invest will invest $7M and Alpha Capital Anstalt will invest $3M.Net...

Seeking Alpha | September 1, 2020

Read More 'EVGN' Stories Here

EVGN Price Returns

1-mo 16.61%
3-mo 50.45%
6-mo 178.51%
1-year 151.49%
3-year -12.47%
5-year -49.85%
YTD 121.71%
2019 -23.23%
2018 -35.50%
2017 -39.80%
2016 -36.65%
2015 -12.60%

Continue Researching EVGN

Want to see what other sources are saying about Evogene Ltd's financials and stock price? Try the links below:

Evogene Ltd (EVGN) Stock Price | Nasdaq
Evogene Ltd (EVGN) Stock Quote, History and News - Yahoo Finance
Evogene Ltd (EVGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.808 seconds.